MSN 571 FINAL EXAM 2023

1) A 40-year old female patient is being followed up for diabetes mellitus. She is currently on

Metformin 1 gram twice a day and has been tolerating it well for about six months. Her hemoglobin

A1c a week ago was 8.9%. The plan is to initiate liraglutide therapy in addition to the metformin.

Which of the following statements is true with regards to liraglutide.

▪ Liraglutide may be stored in the refrigerator or freezer prior to first use.

▪ The brand name is Bydureon

▪ Nausea and/or vomiting are common side effects of therapy

▪ It should be administered intramuscularly into the upper arm.

2) The patient who takes insulin has just been prescribed a beta blocker drug. You recognize that

the interaction of the beta blocker and the insulin may have which result?

▪ Decreased activity of the beta blocker drug

▪ Enhanced activity of the beta blocker drug

▪ Masked signs of hypoglycemia

▪ Masked signs of hyperglycemia

3) The drug of choice for type 2 diabetics is metformin. Metformin:

▪ Increases intestinal uptake of glucose

▪ Decreases glycogenolysis by the liver

▪ Increases the release of insulin from beta cells

▪ Prevents weight gain associated with hyperglycemia

4) Which classification of oral hypoglycemic drugs decreases hepatic glucose production and

increases insulin sensitivity and peripheral glucose uptake?

▪ Sulfonylureas (glyburide)

▪ Meglitinides (glinides)

▪ Biguanide (metformin)

▪ alpha-glycosidase inhibitor (miglitol)

5) A breast-feeding mother is seen in your clinic wanting contraceptive and plans on breast-feeding

for a year. What is an inappropriate choice for this patient?

▪ Depo-Provera 150mg IM every 3 months

▪ Progestin-only OC

▪ Combination OC

▪ Intrauterine device

6) Which of the following is (are) true about oral contraceptives (OCs)?

▪ Estrostep, Ortho Tri-Cyclen, Beyaz, and YAZ are approved for managing acne in women

▪ All the answrs are correct

▪ OCs favorably affect menstrual symptoms: cramps reduction, reduced menstrual flow volume and

duration.

▪ OCs decrease the risk for several disorders, including ovarian cancer, endometrial cancer, ovarian

cysts, pelvic inflammatory disease, benign breast disease.

7) A patient is prescribed ehtinyl estradiol and norelgestromin transdermal contraceptive patch.

Which statement, If made by the patient, indicates an understanding of the use of this drug?

▪ “The patch prevents pregnancy by acting as barrier.”

▪ “I will experience minimal side effects because it is a progestin-only device.”

▪ “I will remove the patch each month and replace it with a new patch 1 week later.”

▪ “I will apply the patch in my vaginal area prior to having sexual intercourse.”